| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 135, 141-147, Copyright © 1994 by Endocrine Society
ARTICLES |
MK Marshall, W Doerrler, KR Feingold and C Grunfeld
Department of Medicine, University of California, San Francisco.
Cytokines induce a number of changes in lipid metabolism that can produce hyperlipidemia. Leukemia inhibitory factor (LIF), a recently discovered cytokine, has been suggested to play a role in the cancer cachexia syndrome through its ability to decrease lipoprotein lipase (LPL) activity. This study explores the mechanism by which LIP decreases LPL activity in cultured adipocytes and determines its effects on fatty acid synthesis and lipolysis to see if it shares the same catabolic effects on fat cells as seen with other cytokines, such as tumor necrosis factor (TNF). LIF decreased LPL activity in cultured adipocytes by 44% compared with an 85% decrease produced by TNF. Although the percent decrease in LPL activity is not as great in LIF- incubated adipocytes as in TNF-incubated adipocytes, the half-maximal doses for both cytokines are similar. LPL messenger RNA levels paralleled LPL activity in the LIF-treated adipocytes, suggesting that the effect of LIF on LPL activity is predominantly mediated through transcriptional regulation. In contrast to TNF, LIF tended to increase the de novo synthesis of fatty acids. Acetyl coenzyme-A carboxylase messenger RNA levels paralleled the changes seen in fatty acid synthesis for both cytokines. LIF caused a small increase in lipolysis, whereas TNF increased lipolysis by greater than 2-fold. These results demonstrate that the catabolic effects of LIF are weaker than those of TNF and are predominantly directed toward decreasing LPL activity, which may contribute to the hyperlipidemia associated with infection, inflammation, and cancer.
This article has been cited by other articles:
![]() |
D. Falconi, K. Oizumi, and J. E. Aubin Leukemia Inhibitory Factor Influences the Fate Choice of Mesenchymal Progenitor Cells Stem Cells, February 1, 2007; 25(2): 305 - 312. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C Hogan and J. M Stephens Effects of leukemia inhibitory factor on 3T3-L1 adipocytes J. Endocrinol., June 1, 2005; 185(3): 485 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Brown, M. S. Boysen, S. Chung, O. Fabiyi, R. F. Morrison, S. Mandrup, and M. K. McIntosh Conjugated Linoleic Acid Induces Human Adipocyte Delipidation: AUTOCRINE/PARACRINE REGULATION OF MEK/ERK SIGNALING BY ADIPOCYTOKINES J. Biol. Chem., June 18, 2004; 279(25): 26735 - 26747. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Laszlo and N. M. Nathanson Src Family Kinase-independent Signal Transduction and Gene Induction by Leukemia Inhibitory Factor J. Biol. Chem., July 18, 2003; 278(30): 27750 - 27757. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Auernhammer and S. Melmed Leukemia-Inhibitory Factor--Neuroimmune Modulator of Endocrine Function Endocr. Rev., June 1, 2000; 21(3): 313 - 345. [Abstract] [Full Text] |
||||
![]() |
M. J. Tisdale Wasting in Cancer J. Nutr., January 1, 1999; 129(1): 243S - 243S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Stephens, S. J. Lumpkin, and J. B. Fishman Activation of Signal Transducers and Activators of Transcription 1 and 3 by Leukemia Inhibitory Factor, Oncostatin-M, and Interferon-gamma in Adipocytes J. Biol. Chem., November 20, 1998; 273(47): 31408 - 31416. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Navasa, D. A. Gordon, N. Hariharan, H. Jamil, J. K. Shigenaga, A. Moser, W. Fiers, A. Pollock, C. Grunfeld, and K. R. Feingold Regulation of microsomal triglyceride transfer protein mRNA expression by endotoxin and cytokines J. Lipid Res., June 1, 1998; 39(6): 1220 - 1230. [Abstract] [Full Text] |
||||
![]() |
H. Kodama, K. Fukuda, J. Pan, S. Makino, A. Baba, S. Hori, and S. Ogawa Leukemia Inhibitory Factor, a Potent Cardiac Hypertrophic Cytokine, Activates the JAK/STAT Pathway in Rat Cardiomyocytes Circ. Res., November 19, 1997; 81(5): 656 - 663. [Abstract] [Full Text] |
||||
![]() |
I. Gloaguen, P. Costa, A. Demartis, D. Lazzaro, A. Di Marco, R. Graziani, G. Paonessa, F. Chen, C. I. Rosenblum, L. H. T. Van der Ploeg, et al. Ciliary neurotrophic factor corrects obesity and diabetes associated with leptin deficiency and resistance PNAS, June 10, 1997; 94(12): 6456 - 6461. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Carroll Jr., D. M. McCoy, S. E. McGowan, R. G. Salome, A. J. Ryan, and R. K. Mallampalli Pulmonary-specific expression of tumor necrosis factor-alpha alters surfactant lipid metabolism Am J Physiol Lung Cell Mol Physiol, April 1, 2002; 282(4): L735 - L742. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |